Sonal Singh to Pancreatitis
This is a "connection" page, showing publications Sonal Singh has written about Pancreatitis.
Singh S. Glucagon-like peptide 1-based drugs and pancreatic safety--reply. JAMA Intern Med. 2013 Oct 28; 173(19):1843-4.
Singh S, Chang HY, Richards TM, Weiner JP, Clark JM, Segal JB. Glucagonlike peptide 1-based therapies and risk of hospitalization for acute pancreatitis in type 2 diabetes mellitus: a population-based matched case-control study. JAMA Intern Med. 2013 Apr 08; 173(7):534-9.
Singh S. Angiotensin-converting enzyme (ACE) inhibitor-induced acute pancreatitis: in search of the evidence. South Med J. 2006 Dec; 99(12):1327-8.
Singh S, Loke YK. Statins and pancreatitis: a systematic review of observational studies and spontaneous case reports. Drug Saf. 2006; 29(12):1123-32.
Singh S. Drug induced pancreatitis might be a class effect of statin drugs. JOP. 2005 Jul 08; 6(4):380; author reply 380-1.
Singh S, Nautiyal A, Dolan JG. Recurrent acute pancreatitis possibly induced by atorvastatin and rosuvastatin. Is statin induced pancreatitis a class effect? JOP. 2004 Nov 10; 5(6):502-4.
Chang HY, Hsieh CF, Singh S, Tang W, Chiang YT, Huang WF. Anti-diabetic therapies and the risk of acute pancreatitis: a nationwide retrospective cohort study from Taiwan. Pharmacoepidemiol Drug Saf. 2015 Jun; 24(6):567-75.